Last checked at Five Motif Bio Non-Executive Directors Leave As Part Of Restructuring
Five Motif Bio Non-Executive Directors Leave As Part Of Restructuring
18 Nov 19 13:50
- Home
- Share Prices
- NEX Exchange Share Prices
- Share Chat
- FX
- News
- Blogs
- RNS
- Media
- Trading
- Finance Tools
- Members
Latest Share Chat
Motif Bio Share News (MTFB)
MTFB Share
Price
MTFB Share
News
MTFB Share
Chat19
MTFB Share
Trades14
MTFB
Live RNS
MTFB Share
Charts
MTFB Level 2
Console
MTFB Live
Share Price
MTFB Broker
Ratings
MTFB Directors
Deals
MTFB Financial
Diary
MTFB
Fundamentals
MTFB Short
Positions
MTFB
Media
MTFB Information
Share Price Information for Motif Bio (MTFB)
Share Price:
0.476
Bid:
0.475
Ask:
0.49
Change:
0.0075
(1.58%)
Spread:
0.015 (3.16%)
Open:
0.548
High:
0.548
Low:
0.476
Yest. Close:
0.475
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.18 Nov 19 13:50Motif Bio Seals Clinical Research Firm Settlement Without Payments
Motif Bio Seals Clinical Research Firm Settlement Without Payments
11 Nov 19 09:52Motif Bio reaches settlement with former clinical research organisation
(Sharecast News) - Motif Bio announced on Monday that its subsidiary Motif BioSciences has reached an agreement with its former clinical research organisation to settle all obligations without further payment.
11 Nov 19 09:40Invesco Cuts Stake In Biopharmaceutifcal Firm Motif Bio To 8.4%
Invesco Cuts Stake In Biopharmaceutifcal Firm Motif Bio To 8.4%
25 Oct 19 17:34Motif Bio announces US Army-funded evaluation of 'iclaprim'
(Sharecast News) - Clinical-stage biopharmaceutical company Motif Bio has signed an agreement with the Walter Reed Army Institute of Research (WRAIR) to conduct pre-clinical testing to evaluate novel combinations with 'iclaprim', to improve safety and efficacy administered by a novel enhanced aerosol technology, it announced on Thursday.
24 Oct 19 16:05Motif Bio Teams Up With US Forces To Look Into Iclaprim Use
Motif Bio Teams Up With US Forces To Look Into Iclaprim Use
24 Oct 19 12:01UK WINNERS & LOSERS SUMMARY: Woodford Trust Up 30% As Schroders Tapped
UK WINNERS & LOSERS SUMMARY: Woodford Trust Up 30% As Schroders Tapped
24 Oct 19 10:31Motif Bio Meeting With US FDA Confirms Need For Another iclaprim Trial
Motif Bio Meeting With US FDA Confirms Need For Another iclaprim Trial
10 Oct 19 11:52Motif Bio To Raise GBP600,000 Via Placing To Fund Major Restructure
Motif Bio To Raise GBP600,000 Via Placing To Fund Major Restructure
2 Oct 19 11:59Motif Bio To Become Cash Shell If Restructuring Proposals Accepted
Motif Bio To Become Cash Shell If Restructuring Proposals Accepted
1 Oct 19 17:09Motif Bio Delays Next Amortisation Date Of Hercules Loan Facility
(Alliance News) - Novel antibiotics-focused biopharmaceutical company Motif Bio PLC said Monday it has agreed with Hercules Capital Inc to postpone the next amortisation date for its loan and date
2 Sep 19 11:39WINNERS & LOSERS SUMMARY: IXICO Rises On Positive Outlook
(Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Monday.----------FTSE 100 - WINNERS----------J up 3.8%. The is
19 Aug 19 10:46Motif Bio Receives US State Funding For Iclaprim Listeria Study
(Alliance News) - Biopharmaceutical firm Motif Bio PLC said Monday that the US government will fund a study on the effectiveness of the iclaprim drug against listeria monocytogenes.Shares a
19 Aug 19 09:29Motif Bio Postpones Next Amortisation Date Of Hercules Loan Facility
(Alliance News) - Biopharmaceutical firm Motif Bio PLC said on Thursday has amended its loan agreement with Hercules Capital Inc, delaying the next amortisation date by one month to September a to
1 Aug 19 11:43Amphion Innovations To Work With Debt Providers To Refinance Facility
(Alliance News) - Amphion Innovations PLC said Wednesday its debt providers have told the company the excess value of the collateral does not meet the terms of an agreed facility between the in at
12 Jun 19 18:16